Idevax is excited to participate for the first time in the Advanced Therapies Congress taking place on March 19 and 20, 2024 in London, UK.
The Congress features speakers from across the entire value chain of cell and gene therapy development with 10 tracks of content over 2 days.
Meet our CEO, Vanessa Vankerckhoven and CTO, Koen Beyers at the Idevax booth. Don’t miss them to learn more about the innovations and considerations that IDEVAX pursues for reliable and easy skin drug delivery using our flagship product VAX-ID in Paris.
Interested in our solutions?
Contact our commercial team!